or
Remember me
Back
Not to say GW doesn't have the cash to buy out a lowly biotech, I just think its funny that they say they have "a lot of money" behind them. LOL
Receive investor kits and email updates from Stockhouse and directly from these companies.
At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!